POSA84 Budget Impact of Larotrectinib for NTRK Fusion Positive Solid Tumors in Greece
Jan 1, 2022, 00:00 AM
10.1016/j.jval.2021.11.229
https://www.valueinhealthjournal.com/article/S1098-3015(21)02024-6/fulltext
Section Title :
Section Order :
10996
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02024-6&doi=10.1016/j.jval.2021.11.229